Total
0
Shares
HITIQ (ASX:HIQ) - CEO, Mike Vegar
CEO, Mike Vegar
Source: Optima Partners
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Concussion management technology company HITIQ (HIQ) partners with Rugby Australia to deploy its impact sensor technology in the rugby league
  • The technology will initially be deployed in Queensland’s premier rugby first grade competition for this season
  • Upon completion of the trial, HITIQ will use the data to enhance player wellbeing and concussion management across all levels
  • HITIQ’s mouthguard sensor detects and measures head impact exposures which allows trainers to manage contact drills to reduce head impact exposure
  • Shares in HITIQ are up 2.56 per cent and trading at 20 cents at 11:26 am AEST

Concussion management technology company HITIQ (HIQ) has partnered with Rugby Australia to deploy its impact sensor technology in the rugby league.

The technology will initially be deployed in Queensland’s premier rugby first grade competition for this season.

Participating teams include Sunnybank, UQ, Easts, Wests and Brothers with all players able to use the technology.

Upon completion of the trial, HITIQ will use the data on an ongoing basis to enhance player wellbeing and concussion management across all levels.

The trial has been endorsed and supported by Chief Medical Officer of Rugby Australia Dr Warren McDonald and will be led by concussion expert Dr Andrew Gardner.

Dr McDonald hopes this trial makes rugby safer for players and enhances Rugby Australia’s understanding of injury.

“Rugby Australia is committed to making the game of rugby safe for all participants. As such, we are exploring a number of technologies to determine their tole in monitoring players, during training and playing rugby, to help us better understand all elements of the game and the links to industry,” Dr McDonald said.

“We hope that the information gained from this program will enhance our current understanding of the mechanisms of unjust and allow us to develop appropriate preventative measures.”

HITIQ’s mouthguard sensor technology detects and measures head impact exposures which allows trainers to identify, manage and manipulate contact drills to reduce head impact exposure.

HITIQ CEO Mike Vegar hopes this partnership will significantly impact players wellbeing.

“We look forward to the partnership with Rugby Australia who are showing strong leadership and progressive thinking towards the serious issue of concussion management,” Mr Vegar commented.

“The implications of a successful outcome from this program will have positive ramifications for Australian Rugby Union.”

Shares in HITIQ were up 2.56 per cent and trading at 20 cents at 11:26 am AEST.

HIQ by the numbers
More From The Market Herald

" Rhinomed (ASX:RNO) receives ethics approval for Rhinoswab trial

Wearable nasal and respiratory company Rhinomed (RNO) has received ethics approval to undertake a clinical trial of Rhinoswab at St Vincents Hospital in
Anteris Technologies (ASX:AVR) - CEO, Wayne Paterson

" Anteris Technologies (ASX:AVR) eyes $5m for DurAVR

Anteris Technologies (AVR) has placed 625,000 new ordinary shares to Melbourne-based global investor L1 Capital to raise $5 million.
Atomo Diagnostics (ASX:AT1) - Managing Director, John Kelly

" Atomo (ASX:AT1) approved to supply and advertise HIV Self-Test

Atomo Diagnostics (AT1) can now supply its HIV self-test to a greater variety of organisations and begin advertising thanks to recent changes made
Starpharma (ASX:SPL) - CEO, Dr Jackie Fairley

" Starpharma (ASX:SPL) signs VIRALEZE supply deal for Vietnam

Starpharma (SPL) has penned an initial deal to distribute and supply its VIRALEZE antiviral nasal spray in Vietnam.